glp-1 glp-2 dual agonist Engineering a potent and long-acting GLP-1/Y2 receptor as a multi-agonist therapy for diabetes and obesity Schematic illustration of monoagonists, dual

Traditionally, the medication was used to control blood sugar, making it a preferred treatment for type 2 diabetes

The GLP-1 class has already proven renoprotective in diabetic nephropathy

It is conceivable that the design of these studies, mainly the low dose of liraglutide used and the short duration follow-up, failed to clearly separate the direct effect of liraglutide on hyperandrogenism from the weight loss derivative one

[DOI] [PMC free article] [PubMed] [Google Scholar] 241.Maudrie T.L., Colon-Ramos U., Harper K.M., Jock B.W., Gittelsohn J

Acute kidney injury (AKI), a common complication with an incidence between 2057% in patients with decompensated liver disease, is often a precursor to CKD. Early detection and optimal management are crucial since serum creatinine is a late indicator of kidney injury